La inyeccion subcutanea abdominal logra distribucion sistemica y ha demostrado eficacia para lesiones remotas en modelos preclinicos
Reduced weight and enhanced mobility mean patients can participate more fully in everyday activities
And by adding the new category of GLP-1 medications, especially for that hard to lose stubborn weight, in lowest effective doses, to our already proven strategies, our patients are now achieving faster, more dramatic, and more sustained weight loss than ever before
K.SaraymenR.OzturkA.et al (2008)
Opioids Linagliptin, a DPP-IV inhibitor, inhibited the expression and acquisition of morphine-induced CPP along with accelerating the extinction and reducing reinstatement of the rewarding effects of morphine (but only at the lower dose), without affecting the locomotor activity in rats (upina et al., 2020)